Evidence map›Paper›PMID 32721246›Full record

ArticleJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research2020

Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells.

Akinobu Ota, Ichiro Hanamura, Sivasundaram Karnan, Shingo Inaguma, Norio Takei, Vu Quang Lam, Shohei Mizuno, Jo Kanasugi, Md Wahiduzzaman, Md Lutfur Rahman and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PBK expression predicts favorable survival in colorectal cancer patients.Virchows Archiv : an international journal of pathology · 2021
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Akinobu OtaDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Ichiro HanamuraDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Sivasundaram KarnanDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Shingo InagumaDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan.
Norio TakeiInstitute for Animal Experimentation, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
Vu Quang LamDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Shohei MizunoDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Jo KanasugiDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Md WahiduzzamanDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Md Lutfur RahmanDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Toshinori HyodoDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Hiroyuki KonishiDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Shinobu TsuzukiDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Hiroshi IkedaDepartment of Pathology, Aichi Medical University School of Medicine, Nagakute, Japan.
Akiyoshi TakamiDivision of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
Yoshitaka HosokawaDepartment of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Aichi Medical University · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Figure: see text] Multiple myeloma (MM) remains an intractable hematological malignancy, despite recent advances in anti-MM drugs. Here, we show that role of PDZ binding kinase (PBK) in MM tumor growth. We identified that interleukin-6 (IL-6) readily increases PBK expression. Kaplan-Meier analysis showed that the MM patients with higher expression of PBK have a significant shorter survival time compared with those with moderate/lower expression of PBK. Knockout of

Indexed as

Gene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticAmino Acid SubstitutionAnimalsApoptosisCell Line, TumorCell ProliferationDisease Models, AnimalDose-Response Relationship, DrugFemaleGene EditingGene Expression ProfilingGene Knockdown TechniquesGenetic LociHumansInterleukin-6Interleukin-6Mitogen-Activated Protein Kinase KinasesPDZ-binding kinaseProtein Kinase InhibitorsSTAT3 Transcription Factorinterleukin-6molecular-targeted therapymultiple myelomaPBKtumor growth

Identifiers

PMID32721246
PMCPMC7462034
OpenAlexW3045586638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.